Page 84 - 《中国药房》2023年24期

[12] NARAINE V S，RISEBROUGH N A，OH P，et al. Health- [23] BOOTH J，OLADAPO A，WALSH S，et al. Real-world
related quality-of-life treatments for severe haemophilia： comparative analysis of bleeding complications and
utility measurements using the Standard Gamble technique health-related quality of life in patients with haemophilia
[J]. Haemophilia，2002，8（2）：112-120. A and haemophilia B[J]. Haemophilia，2018，24（5）：e322-
[13] GRINGERI A，MANTOVANI L G，SCALONE L，et al. e327.
Cost of care and quality of life for patients with hemo‐ [24] KEMPTON C L，RECHT M，NEFF A，et al. Impact of
philia complicated by inhibitors：the COCIS Study Group pain and functional impairment in US adults with haemo‐
[J]. Blood，2003，102（7）：2358-2363. philia：patient-reported outcomes and musculoskeletal
[14] WASSERMAN J，ADAY L A，BEGLEY C E，et al. Mea‐ evaluation in the pain，functional impairment and quality
suring health state preferences for hemophilia：develop‐ of life（P-FiQ）study[J]. Haemophilia，2018，24（2）：
ment of a disease-specific utility instrument[J]. Haemo‐ 261-270.
philia，2005，11（1）：49-57. [25] KOEBERLEIN-NEU J，RUNKEL B，HILBERG T. Cost-
[15] HOOTS W K，EBBESEN L S，KONKLE B A，et al. Se- utility of a six-month programmed sports therapy（PST）in
condary prophylaxis with recombinant activated factor Ⅶ patients with haemophilia[J]. Haemophilia，2018，24（3）：
improves health-related quality of life of haemophilia pa‐ 385-394.
tients with inhibitors[J]. Haemophilia，2008，14（3）： [26] O’HARA J，WALSH S，CAMP C，et al. The impact of se‐
466-475. vere haemophilia and the presence of target joints on
[16] FORSYTH A L，WITKOP M，LAMBING A，et al. Asso‐ health-related quality-of-life[J]. Health Qual Life Out‐
ciations of quality of life，pain，and self-reported arthritis comes，2018，16（1）：84.
with age，employment，bleed rate，and utilization of hemo‐ [27] CARROLL L，BENSON G，LAMBERT J，et al. Real-
philia treatment center and health care provider services： world utilities and health-related quality-of-life data in he‐
results in adults with hemophilia in the HERO study[J]. mophilia patients in France and the United Kingdom[J].
Patient Prefer Adherence，2015，9：1549-1560. Patient Prefer Adherence，2019，13：941-957.
[17] CAVAZZA M，KODRA Y，ARMENI P，et al. Social/eco‐ [28] DAVARI M，GHARIBNASERI Z，RAVANBOD R，et al.
nomic costs and quality of life in patients with haemo‐ Health status and quality of life in patients with severe he‐
philia in Europe[J]. Eur J Health Econ，2016，17（Suppl mophilia A：a cross-sectional survey[J]. Hematol Rep，
1）：53-65. 2019，11（2）：7894.
[18] FISCHER K，KLEIJN P D，NEGRIER C，et al. The asso‐ [29] HOXER C S，ZAK M，BENMEDJAHED K，et al. Utility
ciation of haemophilic arthropathy with health-related valuation of health states for haemophilia and related com‐
quality of life：a post hoc analysis[J]. Haemophilia，2016， plications in Europe and in the United States[J]. Haemo‐
22（6）：833-840. philia，2019，25（1）：92-100.
[19] OSOOLI M，STEEN CARLSSON K，BAGHAEI F，et al. [30] MAHLANGU J，OLDENBURG J，CALLAGHAN M U，
The association between health utility and joint status et al. Health-related quality of life and health status in per‐
among people with severe haemophilia A：findings from sons with haemophilia A with inhibitors：a prospective，
the KAPPA register[J]. Haemophilia，2017，23（3）：e180- multicentre，non-interventional study（NIS）[J]. Haemo‐
e187. philia，2019，25（3）：382-391.
[20] SOUCIE J M，GROSSE S D，SIDDIQI A E，et al. The ef‐ [31] BAEK H J，PARK Y S，YOO K Y，et al. Health-related
fects of joint disease，inhibitors and other complications quality of life of moderate and severe haemophilia pa‐
on health-related quality of life among males with severe tients：results of the haemophilia-specific quality of life in‐
haemophilia A in the United States[J]. Haemophilia，2017， dex in Korea[J]. PLoS One，2020，15（9）：e0238686.
23（4）：e287-e293. [32] LOTFI F，TALEBIANPOUR H，KESHAVARZ K，et al.
[21] WITKOP M，NEFF A，BUCKNER T W，et al. Self- Cost-utility analysis of factor Ⅷ diet therapies prepared
reported prevalence，description and management of pain using blood plasma vs. recombinant technique for patients
in adults with haemophilia：methods，demographics and re‐ with hemophilia A[J]. Daru，2020，28（1）：287-293.
sults from the pain，functional impairment，and quality of [33] TAYLOR S，ROOM J，BARKER K. Physical activity le-
life（P-FiQ）study[J]. Haemophilia，2017，23（4）：556-565. vels in men with haemophilia：a single centre UK survey
[22] BATT K，BOGGIO L，NEFF A，et al. Patient-reported out‐ [J]. Haemophilia，2020，26（4）：718-725.
comes and joint status across subgroups of US adults with [34] BURKE T，ASGHAR S，O’HARA J，et al. Clinical，hu‐
hemophilia with varying characteristics：results from the manistic，and economic burden of severe hemophilia B in
Pain，Functional Impairment，and Quality of Life（P-FiQ） the United States：results from the CHESS US and
study[J]. Eur J Haematol，2018，100（Suppl 1）：14-24. CHESS US+ population surveys[J]. Orphanet J Rare Dis，

· 3018 · China Pharmacy 2023 Vol. 34 No. 24 中国药房 2023年第34卷第24期